Gain of function mutation of the α7 nicotinic receptor: distinct pharmacology of the human α7V274T variant
- 1 February 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 366 (2-3) , 301-308
- https://doi.org/10.1016/s0014-2999(98)00909-1
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Activation and inhibition of the human α7 nicotinic acetylcholine receptor by agonistsNeuropharmacology, 1998
- Mutations at Lipid-Exposed Residues of the Acetylcholine Receptor Affect Its Gating KineticsMolecular Pharmacology, 1998
- Paradoxical allosteric effects of competitive inhibitors on neuronal α7 nicotinic receptor mutantsNeuroReport, 1997
- Mutations in Different Functional Domains of the Human Muscle Acetylcholine Receptor Subunit in Patients with the Slow-Channel congenital Myasthenic SyndromeHuman Molecular Genetics, 1997
- Pharmacology of Nicotine: Addiction and TherapeuticsAnnual Review of Pharmacology and Toxicology, 1996
- Effect of MK-801 at the human α7 nicotinic acetylcholine receptorNeuropharmacology, 1996
- Human α 7 nicotinic acetylcholine receptor responses to novel ligandsNeuropharmacology, 1995
- Nicotinic receptor: an allosteric protein specialized for intercellular communicationSeminars in Neuroscience, 1995
- Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain.Proceedings of the National Academy of Sciences, 1992
- Types of muscarinic response in oocytesLife Sciences, 1980